TransFlex™ Human OCT2 Transporter Plates

TransFlex human OCT2 (SLC22A2) plates are available in a 96-well format with variable plate configurations. The plates are ready to use after an overnight incubation—no change of medium required.

In the graph above, Transflex-OCT2 plate performance is demonstrated by the OCT2-mediated transport of metformin, and the inhibition of that transport by the OCT2 inhibitor quinidine.

TransFlex-OCT2 plate performance is demonstrated by the OCT2-mediated transport of metformin, and the inhibition of that transport by the OCT2 inhibitor quinidine.

 

Catalog NumberPlate Configuration
TFlex-OCT2Half of the wells contain OCT2-expressing cells, and half contain control cells.
TFlex-OCT2-FAll of the wells contain OCT2-expressing cells.
TFlex-MDCK-CAll of the wells contain control cells.
TFlex-Pick2Custom format: plate contains two transporters of your choice, plus control cells.
TFlex-Pick4Custom format: plate contains four transporters of your choice, plus control cells.

Please contact us for more information.

Download the OCT2 User Guide | View Sample Plate Configurations

TransFlex Assay Ready Tutorial